Immunology: Current Research
Open Access

Radiotherapy; Cancer treatment; DNA

Introduction

Principles of radiotherapy

Radiotherapy works on the principle of damaging the DNA within cancer cells, impairing their ability to grow and divide. It delivers ionizing radiation, such as X-rays or gamma rays, to the tumor site. The radiation damages the DNA of cancer cells, leading to their death or inability to replicate. Healthy cells surrounding the tumor are also affected, but they have the ability to repair themselves more efficiently than cancer cells, allowing for a balance between tumor control and minimizing damage to normal tissues.

Materials and Methods

External beam radiotherapy

External beam radiotherapy (EBRT) is the most common form of radiotherapy. It involves directing radiation from a machine outside the body, delivering precise doses to the tumor site. Before treatment, the patient undergoes imaging scans and treatment planning to precisely target the tumor and spare nearby healthy tissues. Modern techniques, such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), allow for highly accurate and precise radiation delivery, maximizing tumor control while minimizing side effects.

Internal radiotherapy (Brachytherapy)

Internal radiotherapy, also known as brachytherapy, involves placing a radioactive source close to or inside the tumor. The radiation is delivered through radioactive implants [1-5] or applicators inserted into or near the tumor. Brachytherapy allows for higher radiation doses to be delivered directly to the tumor while reducing exposure to surrounding healthy tissues. It is commonly used for gynecological, prostate, and breast cancers, among others.

Results and Discussion

Advancements in radiotherapy

Over the years, radiotherapy techniques and technologies have significantly advanced, leading to improved treatment outcomes and reduced side effects. Some notable advancement includes:

• Image-guided radiotherapy (IGRT): IGRT uses imaging techniques, such as CT scans or X-rays, during treatment to precisely locate the tumor before each session. This ensures accurate radiation delivery, especially when treating tumors that may move or change shape, such as those in the lung or prostate.

• Stereotactic radiosurgery (SRS) and stereotactic Body Radiation Therapy (SBRT): SRS and SBRT are highly precise forms of radiotherapy that deliver high doses of radiation to small tumors in a single or limited number of treatment sessions. They are commonly used for brain tumors, lung cancer, and liver metastases.

• Proton therapy: Proton therapy uses protons, which are charged particles, to deliver radiation to the tumor. This technique allows for precise targeting of the tumor while reducing radiation exposure to healthy tissues. Proton therapy is particularly beneficial for pediatric patients and tumors located near critical structures.

• Adaptive radiotherapy: Adaptive radiotherapy involves modifying the treatment plan based on changes observed during the course of treatment. It allows for adjustments in radiation delivery to account for tumor shrinkage, changes in anatomy, or patient-specific factors, ensuring optimal treatment efficacy.

Several factors can influence the effectiveness and outcomes of radiotherapy. Understanding these factors is crucial for optimizing treatment plans and achieving the desired therapeutic effects. here are some key factors that can affect radiotherapy

• Tumor type and stage: The type, location, size, and stage of the tumor can significantly impact the response to radiotherapy. Some tumor types are more radiosensitive, meaning they respond well to radiation, while others may be relatively radioresistant. The stage of the tumor also plays a role, as larger or more advanced tumors may require higher radiation doses or additional treatment modalities.

• Tumor location and accessibility: The location of the [6-8]tumor within the body can influence the delivery of radiation. Tumors situated near critical structures or organs that are more sensitive to radiation may require special techniques, such as image-guided radiotherapy or proton therapy, to minimize damage to healthy tissues while effectively targeting the tumor.

• Patient factors: Individual patient factors can impact the response to radiotherapy. These factors include the patient's overall health, age, immune Table 1 function, and genetic makeup. Patients with comorbidities or compromised immune systems may experience more side effects or have reduced tolerance to radiation. Additionally, genetic variations can influence radiosensitivity and treatment outcomes.

Table 1: It describes the aspects of diseases description.

• Radiobiological factors: Radiobiological factors, such as the intrinsic radiosensitivity of the tumor cells and the repair capacity of healthy tissues, influence treatment outcomes. Factors like tumor oxygenation, cellular proliferation rate, and DNA repair mechanisms can affect the response to radiation and the potential for tumor control.

• Concurrent therapies: Radiotherapy is often used in combination with other treatment modalities, such as chemotherapy or targeted therapy. Concurrent therapies can have synergistic effects or enhance the radiosensitivity of tumor cells. However, the timing, sequencing, and dosage of these therapies need to be carefully coordinated to maximize treatment efficacy while minimizing side effects.

The future of radiotherapy is promising, with ongoing advancements in technology, treatment techniques, and research contributing to improved outcomes and enhanced patient care. Here are some key areas that hold great potential for the future scope of radiotherapy

• Precision and personalized medicine: The integration of advanced imaging, genomics, and molecular profiling allows for more precise targeting of tumors and personalized treatment planning. Techniques such as functional imaging, adaptive radiotherapy, and radiomics enable clinicians to tailor treatment to the individual characteristics of each patient's tumor, optimizing therapeutic outcomes and minimizing side effects.

• Immunoradiotherapy: Combining radiotherapy with immunotherapy holds significant promise. Radiotherapy can enhance the immune response against cancer by stimulating the release of tumor-specific antigens and promoting immune activation within the tumor microenvironment. The synergy between radiotherapy and immunotherapy is being explored to enhance tumor control, improve systemic responses, and potentially achieve long-term remission in various cancer types.

• Particle therapy: Particle therapy, such as proton therapy and carbon ion therapy, delivers radiation using charged particles instead of traditional photons. These techniques offer distinct advantages, including improved dose distribution and better sparing of surrounding healthy tissues. Particle therapy is particularly beneficial for tumors located near critical structures and in pediatric patients, and ongoing research aims to expand its availability and refine treatment protocols.

• Hypofractionation and ultra-hypofractionation: Hypofractionation refers to delivering higher doses of radiation in fewer fractions, while ultra-hypofractionation involves even more condensed treatment schedules. These approaches can improve patient convenience by reducing treatment duration and minimize the overall cost of therapy. Ongoing research is investigating the efficacy and safety of hypofractionated and ultra-hypofractionated radiotherapy across various cancer types.

• Advances in imaging and treatment delivery: Novel imaging technologies, such as real-time MRI-guided radiotherapy, offer enhanced visualization [9-11] and guidance during treatment delivery, allowing for precise tracking of tumor movement and adaptation of treatment plans. Innovative treatment delivery techniques, such as rotational arc therapy and robotic platforms, provide increased flexibility, accuracy, and patient comfort.

Conclusion

The principles of radiotherapy, including damaging cancer cell DNA while sparing healthy tissues, form the foundation of its success. External beam radiotherapy and brachytherapy, along with techniques like IMRT, IGRT, and SRS, have significantly improved treatment precision, allowing for better tumor control while minimizing damage to surrounding healthy tissues. The integration of advanced imaging, genomics, and molecular profiling has further enhanced treatment planning, leading to more personalized and tailored approaches. The future of radiotherapy looks promising, with several areas showing great potential. Precision and personalized medicine, including the combination of radiotherapy with immunotherapy, offer new avenues for improved treatment outcomes and long-term remission. Particle therapy, hypofractionation, and ultra-hypofractionation provide innovative ways to optimize treatment schedules and reduce overall treatment duration. Advances in imaging and treatment delivery, as well as the integration of artificial intelligence, continue to enhance the accuracy, efficiency, and effectiveness of radiotherapy. Radiotherapy has made significant strides in the fight against cancer, improving the chances of cure or long-term disease control while preserving quality of life. The collaboration between healthcare professionals, researchers, and technologists continues to drive progress and shape the future of radiotherapy, ultimately benefiting patients and their families. Overall, radiotherapy remains an indispensable tool in the comprehensive treatment of cancer, offering hope, relief, and improved outcomes for countless individuals affected by this devastating disease. Radiotherapy continues to be an integral component of cancer treatment, providing effective and targeted therapy to combat tumors. The principles of radiotherapy, including damaging cancer cell DNA while sparing healthy tissues, form the foundation of its success. With advancements in technology and techniques, such as external beam radiotherapy, brachytherapy, and precision treatments like IGRT and SRS, radiotherapy has become more precise and personalized, leading to improved outcomes and reduced side effects for cancer patients.

Acknowledgements

The University of Nottingham provided the tools necessary for the research, for which the authors are thankful.

Conflict of Interest

For the research, writing, and/or publication of this work, the authors disclosed no potential conflicts of interest.

1. Staniforth R, Such E (2019) Public health practitioners' perspectives of migrant health in an English region. Public health 175: 79-86.

Indexed at, Google Scholar, Crossref

2. Holroyd TA, Oloko OK, Salmon DA, Omer SB, Limaye RJ, et al. (2020) Communicating recommendations in public health emergencies: The role of public health authorities. Health security 18: 21-28.

Indexed at, Google Scholar, Crossref

3. Doherty R, Madigan S, Warrington G, Ellis J (2019) Sleep and nutrition interactions: implications for athletes. Nutrients 11:822.

Indexed at, Google Scholar, Crossref

4. Jagannath A, Taylor L, Wakaf Z, Vasudevan SR, Foster RG, et al. (2017) The genetics of circadian rhythms, sleep and health. Hum Mol Genet 26:128-138.

Indexed at, Google Scholar, Crossref

5. Somberg J (2009) Health Care Reform. Am J Ther 16: 281-282.

Indexed at, Google Scholar, Crossref

6. Wahner-Roedler DL, Knuth P, Juchems RH (1997) The German health-care system. Mayo Clin Proc72: 1061-1068.

Indexed at, Google Scholar, Crossref

7. Nally MC (2009) Healing health care.J Clin Invest119: 1-10.

Indexed at, Google Scholar, Crossref

8. Weinstein JN (2016) An “industrial revolution” in health care: the data tell us the time has come.Spine41: 1-2.

Indexed at, Google Scholar, Crossref

9. Marshall E C (1989) Assurance of quality vision care in alternative health care delivery systems. J Am Optom Assoc 60: 827-831.

Indexed at, Google Scholar

10. Sohn M (2012) Public health law and ethics. Asia Pacific Journal of Public Health 24:850-850.

Indexed at, Google Scholar, Crossref

11. Adithyan GS, Sundararaman T (2021) Good public health logistics for resilient health systems during the pandemic: Lessons from Tamil Nadu. Indian J Med Ethics: 1-10.

Indexed at, Google Scholar, Crossref